Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
NCT Number: NCT07288710
The trial was designed as a single-center, non-interventional, prospective observational study to explore the role of a multimodal digital device in analyzing subjective and objective recovery in lung cancer patients undergoing sublobar resection versus lobectomy.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Guangzhou, Guangdong, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From 1 day prior to surgery through hospital discharge (assessed up to 15 days).
The electronic patient-reported outcomes questionnaire includes pain, cough, shortness of breath, restless sleep, fatigue, drowsiness, walking difficulties, activity limitation, and distress(0 = no symptom, 10 = most severe).
Time frame: From the day of surgery until the day of discharge, assessed up to 15 days.
Total number of days spent in the hospital from admission to discharge.
Time frame: During the surgical procedure (from anesthesia induction until skin closure).
Duration of the surgery measured in hours.
Time frame: During the surgical procedure (from anesthesia induction until skin closure).
The total count of lymph nodes harvested during the surgical procedure.
The First Affiliated Hospital of Guangzhou Medical University
Other
A Prospective Observational Study to Explore the Early Subjective Evaluation and Objective Recovery in Lung Cancer Patients Undergoing Sublobar Resection Versus Lobectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07506889
Behavior, Disease
Jönköping, Sweden
View Trial DetailsNCT07455552
Disease, Lung Cancer (Diagnosis)
Pusan, South Korea
View Trial DetailsNCT07354854
Disease, Lung Cancer (Diagnosis)
Jinhua, Zhejiang, China
View Trial DetailsNCT07332156
COPD (Chronic Obstructive Pulmonary Disease), Chronic Disease
View Trial Details